Loading
Latest filing published 10 Aug 2023 for Oragenics INC.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Kimberly M. Murphy is a declared insider at 2 companies (board member); the most frequent names are Clarus Therapeutics Holdings, Inc. and Oragenics Inc. In total, 3 filings cover trades dated from 12 December 2021 to 8 August 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 10 August 2023, the filings show a share grant in Oragenics Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations